Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (Q40064054)
Jump to navigation
Jump to search
scientific article published on 30 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial |
scientific article published on 30 July 2008 |
Statements
1 reference
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (English)
1 reference
1 reference
Henrik Zetterberg
1 reference
Kaj Blennow
1 reference
Colin L Masters
1 reference
Craig W Ritchie
1 reference
Lars Lannfelt
1 reference
Stellan Batsman
1 reference
David Ames
1 reference
John Harrison
1 reference
Steve Targum
1 reference
Ross Murdoch
1 reference
Janet Wilson
1 reference
PBT2-201-EURO study group
1 reference
30 July 2008
1 reference
1 reference
Identifiers
1 reference